NCT03765346View on ClinicalTrials.gov

A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure

PHASE1CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

November 5, 2018

Study Completion Date

November 5, 2018

Conditions
Substance Abuse
Interventions
DRUG

Oxycodone IR ADF

Oxycodone IR ADF manipulated/crushed (mass of 540 mg, containing oxycodone hydrochloride 30 mg), in a standardized procedure.

DRUG

Oxycodone API powder

Oxycodone API powder (mass of 30 mg), containing oxycodone hydrochloride 30 mg.

DRUG

Placebo to match oxycodone API powder

Placebo to match oxycodone API powder (mass of 30 mg).

DRUG

Placebo to match manipulated oxycodone IR ADF.

Placebo to match oxycodone IR ADF, manipulated (mass of 540 mg).

Trial Locations (1)

H3P 3P1

Algorithme Pharma, Montreal

Sponsors

Lead Sponsor

Grünenthal GmbH
All Listed Sponsors
lead

Grünenthal GmbH

INDUSTRY